VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,086 | -99.7% | 282,268 | +520.3% | 0.12% | +310.7% |
| Q4 2019 | $747,000 | +20.7% | 45,507 | -2.4% | 0.03% | +7.7% |
| Q3 2019 | $619,000 | -5.9% | 46,623 | -0.2% | 0.03% | 0.0% |
| Q2 2019 | $658,000 | -23.8% | 46,733 | -0.3% | 0.03% | -25.7% |
| Q1 2019 | $863,000 | -64.9% | 46,877 | -53.3% | 0.04% | -31.4% |
| Q4 2018 | $2,461,000 | +113.6% | 100,279 | +99.8% | 0.05% | +15.9% |
| Q3 2018 | $1,152,000 | +20.4% | 50,182 | -0.2% | 0.04% | +12.8% |
| Q2 2018 | $957,000 | +6.1% | 50,260 | -6.1% | 0.04% | +2.6% |
| Q1 2018 | $902,000 | -23.1% | 53,530 | -30.6% | 0.04% | -22.4% |
| Q4 2017 | $1,173,000 | -52.7% | 77,160 | -44.3% | 0.05% | -50.5% |
| Q3 2017 | $2,478,000 | – | 138,446 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |